Ayurveda Medicines VS PPI in Functional Dyspepsia
- Conditions
- Health Condition 1: K30- Functional dyspepsia
- Registration Number
- CTRI/2023/08/057022
- Lead Sponsor
- Central Council for Research in Ayurvedic SciencesNew Delhi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Subjects fulfilling the Rome IV criteria (2016) for FD.ie, Criteria fulfilled for the last 3 months with symptom onset at least 6 months prior to diagnosis with one or more of the following symptoms:
Upper abdominal pain (epigastric pain) or discomfort,
Postprandial fullness,
Early satiation,
Bloating,
Nausea,
Belching.
(3) No evidence of any organic disease
(4) Patients not taking antidepressants, anxiolytics, or antipsychotics.
(5) Patient is willing to participate and able to provide an informed consent
Participants taking antibiotics or nonsteroid anti-inflammatory drugs two weeks before the study.
ii) Gastroesophageal reflux disease
iii) Drug or alcohol abuse
IV)The presence of gastroesophageal malignancy, chronic digestive diseases, and peptic ulcer disease based on history, physical examination, laboratory tests (e.g., white blood cell count, C reactive protein (CRP) or erythrocyte sedimentation rate (ESR) and upper endoscopy.
V) Liver and kidney dysfunction based on laboratory tests.
VI) Systemic disease (e.g., neurological disorders such as Parkinson’s disease) and metabolic diseases (such as diabetes mellitus)
VII) Pregnant and lactating women.
VIII) The history of upper gastrointestinal tract surgery.
IX) Illnesses like heart failure, epilepsy, and previous or current significant psychiatric co morbidity.
X)Testing positive for H.Pylori during screening
XI)Esopghagitis,Barrett’sesophagus,cancer,erosion and ulcer.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method